Chen Pei について
Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), Harbin Medical University, Harbin, China について
Chen Pei について
Department of Pharmacy, Affiliated Hospital of Jining Medical University, Jining, China について
Xu Bing について
Department of Pharmacy, Affiliated Hospital of Dalian Medical University, Dalian, China について
Feng Yan について
Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), Harbin Medical University, Harbin, China について
Li Ke-Xin について
Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), Harbin Medical University, Harbin, China について
Liu Zhuo について
Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), Harbin Medical University, Harbin, China について
Liu Zhuo について
Riley Heart Center, Department of Pediatrics, School Medicine of Indiana University, Indianapolis, USA について
Sun Xun について
Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), Harbin Medical University, Harbin, China について
Lu Xiao-Long について
Department of Pharmacology, Dalian Medical University, Dalian, China について
Wang Lu-Qi について
Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), Harbin Medical University, Harbin, China について
Chen Yu-Wen について
Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), Harbin Medical University, Harbin, China について
Chen Yu-Wen について
Riley Heart Center, Department of Pediatrics, School Medicine of Indiana University, Indianapolis, USA について
Fan Xiong-Xiong について
Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), Harbin Medical University, Harbin, China について
Yang Xin-Ling について
Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), Harbin Medical University, Harbin, China について
Wang Ning について
Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), Harbin Medical University, Harbin, China について
Qiao Guo-Fen について
Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), Harbin Medical University, Harbin, China について
Li Bai-Yan について
Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Medicine Research, Ministry of Education), Harbin Medical University, Harbin, China について
Brain Research Bulletin について
合併症 について
遺伝子 について
血圧 について
卵巣切除 について
免疫染色 について
免疫組織化学 について
マイクロインジェクション について
ダウンレギュレーション について
代謝異常 について
ラット について
血清 について
FGF受容体 について
FGF【成長因子】 について
血清中濃度 について
性差 について
FGF-21 について
圧反射求心路 について
血圧(BP)調節の神経制御 について
原発性高血圧 について
向精神薬の基礎研究 について
神経の基礎医学 について
中枢神経系 について
圧反射 について
SHR について
本態性高血圧 について